Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    infectious disease

    Chlamydia trachomatis infection

    Also known as: Chlamydia, Genital chlamydial infection, Urogenital chlamydiasis, Chlamydial sexually transmitted infection

    Chlamydia trachomatis is a common bacterial infection spread through sexual contact. While many people have no symptoms, it can cause discharge, dysuria, and pelvic discomfort. Medical testing, antibiotic treatment, partner management, and follow-up are essential. If left untreated, the infection can ascend, leading to pelvic inflammatory disease (PID), which carries risks of chronic pelvic pain, ectopic pregnancy, and infertility. Chinese medicine should only be used as adjunctive support for symptoms after formal medical assessment; it is not a treatment for infection and cannot confirm clearance. The evidence cited here includes a PID review, an abstract-free letter, a mouse-model study, and a review of infertility models. None of these demonstrates that acupuncture or the listed formulas are clinically effective for chlamydia, and experimental mechanisms do not prove benefits for patients.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Complete the full course of prescribed antibiotics and attend all follow-up consultations and repeat diagnostic testing; symptomatic resolution is not indicative of microbiological clearance.
    • •Adhere to sexual health guidelines by abstaining from sexual contact for the duration of the treatment course and until all partners have completed therapy; utilise barrier contraception for subsequent encounters.
    • •Utilise confidential partner-notification services and consult a clinician regarding comprehensive screening for other sexually transmitted infections.
    • •Avoid vaginal douching and the application of topical irritants; maintain regular nutritional intake, adequate sleep hygiene, and gentle physical activity during convalescence.

    Cautions & Contraindications

    See sources
    • •Do not use acupuncture or herbs instead of antimicrobial treatment, or delay referral for suspected PID. The supplied PID review emphasises early diagnosis and appropriate antimicrobials; it does not establish acupuncture safety or efficacy.[]
    • •Defer elective lower-abdominal treatment when acute pelvic pain or possible ectopic pregnancy has not been assessed. This precaution follows the need to exclude serious PID-related complications, not a needling trial.[]
    • •Do not extrapolate the supplied mouse decoction findings to human infection clearance, fertility protection or safety of the listed formulas; they are different interventions without supplied clinical validation.[]
    • •Do not offer stem-cell approaches as established treatment for chlamydia-associated infertility on the basis of the supplied model-focused review; it identifies clinical translation and safety uncertainties.[]

    When to reassess or seek care again

    See sources

    Review adjunctive care within 7–14 days, recording pain on a 0–10 scale, urinary and discharge symptoms, bowel symptoms, sleep, daily function and adverse effects. Confirm engagement with prescribed treatment and partner management. Suspected PID needs medical reassessment within 48–72 hours of treatment initiation, or sooner if worsening; do not wait for the adjunctive review. Persistent symptoms require assessment for reinfection, treatment problems or another diagnosis, not automatic formula changes. Infection clearance and repeat-testing timing remain the treating clinician's responsibility. Stop adjunctive treatment if no measurable benefit after 2–4 visits.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. International journal of surgery (London, England) · 2026
    2. Frontiers in endocrinology · 2026
    3. Journal of traditional and complementary medicine · 2026
    4. Frontiers in endocrinology · 2025

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.